Bertin Bioreagent

anti-TAF4 (formerly TAFII135), mAb (2B9)

As low as CHF 664.00
In stock
Only %1 left
BRT-G01082-R100100 µlCHF 664.00
NEW
 
More Information
Product Details
Synonyms Transcription Initiation Factor TFIID Subunit 4; TATA-Box Binding Protein-Associated Factor 4; TAFII130; TAFII135; TBP-associated Factor 4; RNA Polymerase II TBP-associated Factor Subunit C
Product Type Monoclonal Antibody
Properties
Clone 2B9
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Synthetic peptide.
Application ELISA, Western Blot, Immunoprecipitation, Immunofluorescence. Recommended dilutions: 1/500-1/5000.
Specificity Recognizes human and mouse TAF4.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
TAF4 is a transcription cofactor and a key subunit of the TFIID complex, which is crucial for the initiation of RNA polymerase II-dependent transcription. It helps regulate gene expression by interacting with other components of the TFIID complex. TAF4 is a core component of the TFIID complex, which is responsible for promoter recognition and recruitment of RNA polymerase II to initiate transcription. TAF4 participates in chromatin remodeling, which is essential for transcription. By interacting with other coactivators and chromatin-modifying enzymes, it helps make DNA more accessible to the transcription machinery. TAF4 is essential for proper gene expression during development. It is particularly involved in embryonic development and tissue-specific gene regulation. Mutations or dysregulation of TAF4 can lead to defects in developmental processes and cell differentiation. Altered expression of TAF4 has been implicated in certain cancers. TAF4 mutations may be associated with neurodevelopmental diseases.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.